Protheragen is a biotechnology company dedicated to advancing the frontiers of genetic code expansion through the development and application of orthogonal tRNA/aaRS technologies. By enabling site-specific incorporation of non-canonical amino acids (ncAAs), we provide powerful molecular tools and integrated solutions for pharmaceutical R&D, synthetic biology, and diagnostic innovation. Our team combines expertise in molecular biology, protein engineering, and nucleic acid chemistry to support academic and industrial partners around the globe.
Modular Engineering Platform
Customizable Service Packages
In-House Library Generation
Workflow Integration
Our team consists of scientists with deep experience in RNA biology, synthetic chemistry, and bioengineering, enabling us to design solutions with both innovation and rigor.
We follow strict internal standards for reagent synthesis, validation, and quality control, ensuring reproducibility and reliability across projects.
We prioritize clear communication and technical support, working closely with clients from project design to final delivery to ensure alignment with research goals.
A specialized platform advancing genetic code expansion through orthogonal tRNA/aaRS technologies, enabling precise ncAA incorporation for biotherapeutic development, synthetic biology, and diagnostics.